Literature DB >> 33242139

Reply to: The course of lung oligometastatic colorectal cancer may be a reflection of selection for treatment rather than an effect of stereotactic body radiotherapy.

Luca Nicosia1, Francesco Cuccia2, Filippo Alongi2,3.   

Abstract

Entities:  

Year:  2020        PMID： 33242139     DOI： 10.1007/s00066-020-01710-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  12 in total

1.  Intraarterial cisplatin infusion: nursing implications.

Authors:  N M Leahy
Journal:  J Neurosci Nurs       Date:  1986-10       Impact factor: 1.230

2.  Beyond Oligometastases.

Authors:  David A Palma; Glenn S Bauman; George B Rodrigues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-06-01       Impact factor: 7.038

3.  Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy.

Authors:  Carlo Greco; Oriol Pares; Nuno Pimentel; Vasco Louro; Javier Morales; Beatriz Nunes; Joana Castanheira; Carla Oliveira; Angelo Silva; Sofia Vaz; Durval Costa; Michael Zelefsky; Richard Kolesnick; Zvi Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-21       Impact factor: 7.038

4.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

5.  Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study.

Authors:  Rosario Mazzola; Sergio Fersino; Giuseppe Ferrera; Giovanni Targher; Vanessa Figlia; Luca Triggiani; Nadia Pasinetti; Antonio Lo Casto; Ruggero Ruggieri; Stefano Maria Magrini; Filippo Alongi
Journal:  Med Oncol       Date:  2018-08-04       Impact factor: 3.064

6.  Tumor self-seeding by circulating cancer cells.

Authors:  Mi-Young Kim; Thordur Oskarsson; Swarnali Acharyya; Don X Nguyen; Xiang H-F Zhang; Larry Norton; Joan Massagué
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

7.  Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.

Authors:  Luca Nicosia; Francesco Cuccia; Rosario Mazzola; Francesco Ricchetti; Vanessa Figlia; Niccolò Giaj-Levra; Michele Rigo; Davide Tomasini; Nadia Pasinetti; Stefanie Corradini; Ruggero Ruggieri; Filippo Alongi
Journal:  Strahlenther Onkol       Date:  2020-05-12       Impact factor: 3.621

8.  Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease.

Authors:  Alina Mihai; Yijia Mu; John Armstrong; Mary Dunne; Sushil Beriwal; Luke Rock; Pierre Thirion; Dwight E Heron; Brian Healy Bird; Jennifer Westrup; Conleth Gerard Murphy; M Saiful Huq; Raymond McDermott
Journal:  J Radiosurg SBRT       Date:  2017

9.  The evolutionary history of lethal metastatic prostate cancer.

Authors:  Christopher Foster; Douglas Easton; Ultan McDermott; David C Wedge; G Steven Bova; Gunes Gundem; Peter Van Loo; Barbara Kremeyer; Ludmil B Alexandrov; Jose M C Tubio; Elli Papaemmanuil; Daniel S Brewer; Heini M L Kallio; Gunilla Högnäs; Matti Annala; Kati Kivinummi; Victoria Goody; Calli Latimer; Sarah O'Meara; Kevin J Dawson; William Isaacs; Michael R Emmert-Buck; Matti Nykter; Zsofia Kote-Jarai; Hayley C Whitaker; David E Neal; Colin S Cooper; Rosalind A Eeles; Tapio Visakorpi; Peter J Campbell
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

10.  Pulmonary metastasectomy in colorectal cancer: health utility scores by EQ-5D-3L in a randomized controlled trial show no benefit from lung metastasectomy.

Authors:  Chris Brew-Graves; Vernon Farewell; Kathryn Monson; Mišel Milošević; Norman R Williams; Eva Morris; Fergus Macbeth; Tom Treasure; Lesley Fallowfield
Journal:  Colorectal Dis       Date:  2020-10-21       Impact factor: 3.788
View more
  2 in total

1.  Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors.

Authors:  Francesco Cuccia; Rosario Mazzola; Vanessa Figlia; Niccolò Giaj-Levra; Luca Nicosia; Francesco Ricchetti; Michele Rigo; Giorgio Attinà; Claudio Vitale; Edoardo Pastorello; Ruggero Ruggieri; Filippo Alongi
Journal:  Strahlenther Onkol       Date:  2022-05-02       Impact factor: 4.033

2.  Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses.

Authors:  Norman R Williams; Hannah Patrick; Francesca Fiorentino; Alexander Allen; Manuj Sharma; Mišel Milošević; Fergus Macbeth; Tom Treasure
Journal:  Eur J Cardiothorac Surg       Date:  2022-06-15       Impact factor: 4.534
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.